TVM Life Science Management GmbH

PRESS RELEASE

published on 02/06/2024 at 10:10, 2 years 2 months ago

TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE
TVM CAPITAL LIFE SCIENCE CO-LEADS $16 MILLION SERIES A FINANCING ROUND FOR VEKTOR MEDICAL TO REVOLUTIONIZE ARRHYTHMIA CARE. TVM Capital Life Science announces a $16 million Series A financing for Vektor Medical, a pioneer in non-invasive, AI-based arrhythmia analysis technology

Series A Financing TVM Capital Life Science Vektor Medical Arrhythmia Care AI-based Analysis
PRESS RELEASE

published on 01/31/2024 at 10:00, 2 years 2 months ago

TVM CAPITAL LIFE SCIENCE ANNOUNCES €8 MILLION INVESTMENT IN MYO TO REVOLUTIONIZE ELDERLY CARE VIA INNOVATIVE, EASY-TO-USE APP
TVM Capital Life Science invests €8 million in Myosotis GmbH to revolutionize elderly care with innovative app, strengthening healthcare communication and administrative processes in care homes

Investment TVM Capital Life Science Myosotis GmbH Innovative App Elderly Care
PRESS RELEASE

published on 07/20/2023 at 14:00, 2 years 8 months ago

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis
PRESS RELEASE

published on 03/17/2023 at 14:00, 3 years ago

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
PRESS RELEASE

published on 02/23/2023 at 14:00, 3 years 1 month ago

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
PRESS RELEASE

published on 02/08/2023 at 14:00, 3 years 2 months ago

TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients
PRESS RELEASE

published on 02/01/2023 at 14:00, 3 years 2 months ago

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Published on 04/09/2026 at 16:00, 2 hours 55 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 4 hours 15 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 4 hours 55 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 5 hours 25 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Published on 04/09/2026 at 13:30, 5 hours 25 minutes ago

ESGold Advances Toward Production and Exploration Drilling as Mill Buildout Progresses in Parallel

View all ACCESSWIRE

Published on 04/09/2026 at 18:15, 40 minutes ago

REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:59, 2 hours 56 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 2 hours 58 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 3 hours 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc
Published on 04/09/2026 at 15:39, 3 hours 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS

Published on 04/09/2026 at 18:35, 20 minutes ago

Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:35, 1 hour 20 minutes ago

SUEZ - FY 2025
Published on 04/09/2026 at 15:57, 2 hours 57 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 11 hours 55 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day ago

Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE

News